Robot-assisted surgery compared with camera-guided keyhole surgery for thymoma
Compares robot-assisted and video-assisted surgery to remove thymoma in adults.
Key facts
- Who runs it
- Shanghai Pulmonary Hospital, Shanghai, China
- Where
- China2 sites in 1 countryChoose a country to see its sites
- Trial code
- Registry title
- Robot-assisted vs VATS for Thymoma
- Status
- Recruiting
- People taking part
- 304 people, planned
- Started
- 20 Nov 2023
- Expected to end
- 19 Sept 2030
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- RATS for Thymectomy
- VATS for Thymectomy
- Record updated
- 29 February 2024
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with a thymoma (a tumour of the thymus gland in the chest) who need surgery to remove the thymus. It compares robot-assisted surgery with video-assisted keyhole surgery.
- Age
- 18 years or older and under 75 years.
- Sex
- All sexes can join.
- Disease stage
- Clinical stage I to IIIA (AJCC-UICC TNM system). The tumour must be smaller than 5cm (2 in) at its widest. People may have myasthenia gravis symptoms or not. Daily activity score (ECOG) must be 0 or 1.
- Earlier treatment
- No earlier treatment for thymoma, such as chemotherapy or radiotherapy.
- Biomarker or test result
- Blood tests must show: hemoglobin ≥ 10.0 g / dL, neutrophils ≥ 1.5 × 109 / L, platelets ≥ 100 × 109 / L, creatinine clearance ≥ 60 mL/min, and liver and clotting tests within set limits.
Main reasons for not taking part
- Myasthenia gravis crisis, or earlier surgery in the middle of the chest or on the heart.
- Body mass index (BMI) of 30 or more.
- Severe liver, kidney or chronic lung disease, or other uncontrolled illness.
- Other cancers or blood diseases, chronic pain or use of opioid painkillers before surgery.
- Chest wall deformity, mental disorders, pregnancy or breastfeeding.
The registry criteria, word for word
Show all 21 criteriaShow less
Who can take part
- ) The age of the subjects on the day of signing the informed consent was ≥ 18 years old and < 75 years old, regardless of gender
- ) Chest thin-layer CT and MR showed anterior mediastinal space-occupying lesions, combined with relevant hematological indicators, the patient was clinically diagnosed as a thymic epithelial tumor with or without myasthenia gravis ( MG ) symptoms
- ) need to accept thymectomy surgery
- ) Clinical stage I to IIIA ( AJCC-UICC TNM staging system )
- ) The maximum diameter of the lesion < 5cm
- ) physical condition score 0 or 1 ( Eastern Cooperative Oncology Group ECOG scoring system )
- ) Have not received any anti-thymoma therapy before, including but not limited to systemic chemotherapy, radiotherapy, etc.
- ) Preoperative major organ function meets the following criteria : Bone marrow function: hemoglobin ≥ 10.0 g / dL ( no blood transfusion within 28 days before hemoglobin examination ), absolute neutrophil count ≥ 1.5 × 109 / L, platelet count ≥ 100 × 109 / L ( no transfusion of apheresis platelets or IL-11 treatment within 14 days before platelet count examination ) ; coagulation function : INR and PT < 1.5 × ULN, APTT ≤ 1.5 × ULN ; liver function: transaminase ( ALT and AST ) ≤ 2.5 × ULN; total bilirubin ≤ 1.5 × ULN ( Gilbert's syndrome or liver metastasis subjects total bilirubin ≤ 2.5 × ULN ) ; renal function: serum creatinine clearance rate ≥ 60 mL/min ( calculated according to the Cockcroft-Gault formula )
- ) voluntarily participated in and were able to undergo robot-assisted or thoracoscopic thymectomy, and complied with the study follow-up plan
Who cannot take part
- ) had undergone mediastinal surgery or cardiac surgery
- ) combined with severe chronic lung diseases such as COPD, asthma, or interstitial lung disease
- ) suffering from uncontrolled heart, kidney, gastrointestinal, and infectious diseases and other complications
- ) patients with other malignant tumors or hematological diseases
- ) have mental disorders, such as anxiety disorders
- ) Patients with severe liver and kidney dysfunction ( ALT and/or AST more than three times the upper limit of normal, Cr more than the upper limit of normal )
- ) Patients with myasthenia gravis crisis
- ) body mass index ( BMI ) ≥ 30
- ) combined with chronic pain or preoperative use of opioid analgesics
- ) patients with thoracic deformity or combined with pectus carinatum and pectus excavatum
- ) pregnant and/or lactating women
- ) is currently participating in other interventional clinical studies
The main criteria, as questions
These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Are you between 18 and 75 years old?
This trial is currently available in China.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The aim of this study is to explore the advantages of robot-assisted thymectomy in long-term survival benefits and short-term clinical efficacy compared with video-assisted thoracoscopic thymectomy based on a multi-center, prospective, randomized controlled clinical trial.
The 2 groups in the trial
- RATS for ThymectomyTreatment being tested
The operator of the surgical incision and the route of entry were determined, and the endoscope and surgical instruments were inserted through the operating hole. The phrenic nerve and diaphragm began to gradually separate upward while avoiding nerve damage. Subsequently, the innominate vein was dissected to observe the branches of the thymus vessels and clamped with a 5 mm Hem-o-Lok clamp. Continue to dissect the left side of the thymus until near the phrenic nerve. After the thymus was removed entirely, it was placed in a bag and removed through an incision. After the operation, a 28 Fr chest tube was placed through the incision to the chest top. An 18 G central venous catheter was placed at the level of the posterior axillary line to the posterior costophrenic angle, and about 10 cm was inserted.
- VATS for ThymectomyExisting treatment, for comparison
The main operation principles and procedures of the operation are basically similar to those of the RATS and are completed under video-assisted thoracoscopic surgery.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Comparison of Short-term and Longterm Outcomes Between Robot-assisted Thoracoscopy and Television-assisted Thoracoscopy Surgery Forthymoma : a Multicenter, Prospective, Randomized Controlled Study
- Plain-language title
- Robot-assisted surgery compared with camera-guided keyhole surgery for thymomaGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 15 November 2026.
- Criteria questions
- Built from NCT06029621, who can take part
- Record updated
- 29 February 2024